• Psychedelics in Medicine the History and Science and the Risks

  • Jan 6 2025
  • Durée: 1 h et 12 min
  • Podcast

Psychedelics in Medicine the History and Science and the Risks

  • Résumé

  • Send us a text

    Mel interviews Karina Sergi, MS, MFT Director, Psychedelic Therapy Training; Director, Diversity, Equity & Inclusion and Keith Heinzerling, MD Director, Treatment & Research In Psychedelics (TRIP) Center; Addiction Medicine.

    We discuss psychedelic associated therapy, ketamine, DMT, Psilocybin, Hallucinogen persisting perception disorder (HPPD, Ontological shock, Psychnaughts and so much more as we continue our series on mental health treatment options

    The Treatment and Research in Psychedelics clinic (TRIP) located at Pacific Neuroscience Institute. Their website:
    https://www.pacificneuroscienceinstitute.org/treatment-research-in-psychedelics/


    Support the show

    Voir plus Voir moins

Ce que les auditeurs disent de Psychedelics in Medicine the History and Science and the Risks

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.